{"nct_id":"NCT04052204","title":"Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors","status":"TERMINATED","status_verified_date":"2021-09","start_date":"2019-12-30","start_date_type":"ACTUAL","primary_completion_date":"2020-09-29","primary_completion_date_type":"ACTUAL","completion_date":"2020-09-29","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["PFE"]}